Western Blotting Market (By Products: Electrophoresis Blotting Systems, Reagents & Kits, Transfer Membranes; By Application: Scientific Research, Medical Diagnostics, Agricultural Application, Food & Beverages, Other Applications; By End-use: Diagnostics Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global western blotting market size was USD 989.47 million in 2023, calculated at USD 1,053.98 million in 2024 and is expected to reach around USD 1,860.86 million by 2033, expanding at a CAGR of 6.52% from 2024 to 2033. Western blotting offers more benefits than another antibody-based detection assay; it requires fewer reagents, many analyses can be done with the same protein transfer, and it provides accurate qualitative and quantitative data about the protein of interest. These factors help to the growth of the market.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. western blotting market size was exhibited at USD 249.35 million in 2023 and is projected to be worth around USD 478.85 million by 2033, poised to grow at a CAGR of 6.74% from 2024 to 2033.
North America dominated the western blotting market in 2023. Increased focus on personalized medicine, increased research funding, and rising investment in proteomics research help the growth of the market in the North American region. Increased demand for synthetic biology solutions, supportive government initiatives, and decreasing sequencing costs help the growth of the biotechnology industries in the United States.
Asia Pacific is estimated to be the fastest-growing during the forecast period of 2024-2033. China is the leading country for the growth of the western blotting market in the Asia Pacific region. Increasing demand for medical diagnostics and growing pharmaceutical industries in China contribute to the growth of the market.
Western blotting technique or protein immunoblot is used for the detection and quantification of specific protein molecules in the given complex protein sample. The Western blotting market deals with industries for applications including food & beverages, agriculture, medical diagnostics, scientific research, and other applications. Western blotting is the most commonly used analytical method in fundamental cell and molecular biology research, disease, and drug development to examine molecular function. The benefits of western blotting include its use in protein separation by electrophoresis, followed by western blotting, which can offer more precision than other antibody-based detection assays. ELISA. The western blotting process requires the use of a small number of reagents, and the same protein transfer may be used for the various analyses. These factors help to the growth of the market.
Report Coverage | Details |
Market Size by 2033 | USD 1,860.86 Million |
Market Size in 2023 | USD 989.47 Million |
Market Size in 2024 | USD 1,053.98 Million |
Market Growth Rate from 2024 to 2033 | CAGR of 6.52% |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Products, Application, End-use, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Rising prevalence of HIV worldwide
For the detection of HIV, the western blotting method is highly used. The western blot test separates the blood and detects the specific proteins called HIV antibodies that indicate HIV infection. For a positive HIV diagnosis, a western blot test is used. The rising prevalence of HIV worldwide helps to the growth of the western blotting market. Early diagnosis and testing are important for effective prevention and management of HIV. Western blotting is also used to ensure a positive ELISA. Western blotting test is a simple blood test. It does not require preparation or fasting in any way. These factors help to the growth of the market.
Need for alternative technologies
There is a need for alternative technology due to the disadvantages of western blotting, including incidental oxidation or phosphorylation of proteins that may result in multiple bands becoming visible after sampling the process. Subject to false or subjective results. Western blotting is a challenging technique that requires well-trained staff. It requires primary antibodies for the protein of interest, and it may exhibit off-target binding, which leads to poorer results. These factors can hamper the growth of the western blotting market.
Advanced technologies
In clinical and research settings, the western blotting technique is used to identify proteins and characterize their levels. There is an opportunity for western blotting improvement by creating more sensitive, advanced, and automatic techniques. New methods like microchip electrophoresis, automated microfluid western blotting, DigiWest, capillary electrophoresis, and single-cell resolution western blot have all been developed to reduce problems that are linked with western blotting techniques. For western blotting, innovative instrument developments and increased sensitivity offer new possibilities for increasing the clinical performance of the western blot. These factors help to the growth of the western blotting market.
The electrophoresis blotting systems segment dominated the market in 2023, and the segment is expected to grow the fastest during the forecast period. Electrophoresis blotting, also known as electroblotting, is a technique used in immunogenetics, molecular biology, and biochemistry to transfer nucleic acid or proteins onto a membrane by using nitrocellulose or PVDF after gel electrophoresis. This technique is used for nucleic acid separation or immobilization of proteins on a solid membrane. The electrophoresis blotting system benefits include improved diagnosis, throughput, fast & easy technique, mass sensitivity, automation, and consistent and dependable results. These factors help the growth of the electrophoresis blotting system segment and contribute to the growth of the western blotting market.
The medical diagnostics segment dominated the market in 2023 and is expected to grow fastest during the forecast period. Western blotting is a widely used analytical technique in immunogenetics and molecular biology. In medical diagnostics, western blotting is used for the diagnosis of infectious diseases like HIV, prion disease, hepatitis B diseases, and autoimmune diseases like paraneoplastic disease. Western blotting can provide confirmed results for medical diagnostics because their results are quicker and less ambiguous than other methods. These factors help to the growth of the medical diagnostics segment and contribute to the growth of the western blotting market.
The scientific research segment is expected to grow significantly during the forecast period. Western blotting is a leading and widely used technique in scientific and biomedical research. Researchers can detect specific proteins from a complex mixture of proteins extracted from cells by using western blotting, which helps detect diseases. Western blotting is a simple, rapid, unique, and widely used tool with definite results and easy interpretation. The benefits of western blotting in scientific research include high specificity, semi-quantitative analysis, flexibility, ease of use, and detection sensitivity, which can help the growth of the scientific research segment and contribute to the growth of the western blotting market.
The diagnostic laboratories segment dominated the western blotting market in 2023 and is expected to grow fastest during the forecast period. The western blotting is highly used in diagnostic laboratories. The benefits of western blotting include protein detection, quantitative analysis, safety, and sensitivity. The clinical applications of western blotting include diagnosis of infectious diseases like Lyme disease, HIV, and hepatitis C, and autoimmune disorders like myositis and paraneoplastic disease. These factors help to the growth of the diagnostic laboratories segment and contribute to the growth of the market.
Segments Covered in the Report
By Products
By Application
By End-use
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Western Blotting Market
5.1. COVID-19 Landscape: Western Blotting Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Western Blotting Market, By Products
8.1. Western Blotting Market Revenue and Volume, by Products, 2024-2033
8.1.1 Electrophoresis Blotting Systems
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Reagents & Kits
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Transfer Membranes
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Western Blotting Market, By Application
9.1. Western Blotting Market Revenue and Volume, by Application, 2024-2033
9.1.1. Scientific Research
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Medical Diagnostics
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Food & Beverages
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Other Applications
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Western Blotting Market, By End-use
10.1. Western Blotting Market Revenue and Volume, by End-use, 2024-2033
10.1.1. Diagnostics Laboratories
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Research Institutions
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Pharmaceutical & Biotechnology Companies
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Western Blotting Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 12. Company Profiles
12.1. Leinco Technologies
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Takara Bio Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. ICL, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cell Signaling Technology, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. GenScript
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ElabScience Biotechnology Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. HiMedia Laboratories
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Azure Biosystem Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Advansta Inc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. SBH Sciences
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client